November 2011 PMID 22051327

Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.

Dariush Mozaffarian, Jason H Y Wu

Download social card

Mentions

Peak: 1 in Feb 2023

across 5 sources since Feb 2023

Extended reach

1,523,779

potential audience

Total likes

18,227

Video views

1,522,394

Mentions per month

Feb 2023 – Oct 2025

Where it's discussed

News21 articles
Blogs10 articles
YouTube4 videos
Facebook4 posts
X / Twitter2 posts

AI synopsis

What people are saying

The collective discussions demonstrate strong enthusiasm for the article's exploration of how omega-3 fatty acids influence cardiovascular health, with references to molecular pathways and clinical implications. Phrases like 'potential game-changer' and mentions of molecular mechanisms reflect a high level of interest and engagement, while recognition of the research’s significance underscores its perceived impact.

AgreementModerate agreement

Most posts recognize the significance of the research, with some expressing support or alignment with its findings.

InterestHigh interest

The discussions show high curiosity and curiosity about the subject, often highlighting its relevance to health and science.

EngagementModerate engagement

Posts delve into the molecular mechanisms and potential clinical implications, indicating active engagement.

ImpactModerate impact

While some posts acknowledge the importance of the research, others suggest it could influence future clinical practices or further studies.

Abstract in brief

N3 polyunsaturated fatty acids (PUFAs), especially from seafood, can lower risk factors for heart disease by reducing plasma triglycerides, resting heart rate, and blood pressure, and potentially improving heart function and reducing inflammation.
These fatty acids influence various molecular pathways, such as altering cell membrane properties, interacting with membrane channels, regulating gene expression, and converting into bioactive metabolites, which collectively contribute to their cardiovascular effects.
Evidence from observational studies and clinical trials suggests n3 PUFAs are most effective in reducing mortality from coronary heart disease and sudden cardiac death, but their impact on other cardiovascular conditions remains uncertain, highlighting areas for further research.

Read the full abstract